Cita APA

Ortea García, I., Roschitzki, B., Ovalles, J. G., Longo, J. L., de la Torre, I., Gonzalez, I., . . . González, I. (2012). Discovery of serum proteomic biomarkers for prediction of response to infliximab (a monoclonal anti-TNF antibody) treatment in rheumatoid arthritis: An exploratory analysis.

Citación estilo Chicago

Ortea García, Ignacio, B. Roschitzki, J G. Ovalles, J L. Longo, I. de la Torre, I. Gonzalez, Juan Jesús Gómez-Reino Carnota, Antonio González Martínez-Pedrayo, y I. González. Discovery of Serum Proteomic Biomarkers for Prediction of Response to Infliximab (a Monoclonal Anti-TNF Antibody) Treatment in Rheumatoid Arthritis: An Exploratory Analysis. 2012.

Cita MLA

Ortea García, Ignacio, et al. Discovery of Serum Proteomic Biomarkers for Prediction of Response to Infliximab (a Monoclonal Anti-TNF Antibody) Treatment in Rheumatoid Arthritis: An Exploratory Analysis. 2012.